Read + Share
Amedeo Smart
Independent Medical Education
Ruff CT, Goodrich EL, Sabatine MS. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. Reply. N Engl J Med 2025;392:1557.PMID: 40239083
Email
LinkedIn
Privacy Policy